William R Arnold

4PUBLICATIONS
9CO-AUTHORS
Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 02, 2024
Structural basis of TRPV1 modulation by endogenous bioactive lipids.

William R Arnold, Adamo Mancino, Frank R Moss

|Sep 22, 2019
Polymorphisms of CYP2C8 Alter First-Electron Transfer Kinetics and Increase Catalytic Uncoupling.

William R Arnold, Susan Zelasko, Daryl D Meling

|Oct 05, 2018
Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 Epoxygenase.

Lauren N Carnevale, Andres S Arango, William R Arnold

|Apr 10, 2018
An Emerging Pathway of Doxorubicin Cardiotoxicity Mediated through CYP2J2.

William R Arnold, Aditi Das

Pageof 1